H40.131

Clinical Causes: The primary cause of pigmentary glaucoma is a genetic predisposition that affects the iris and its interaction with the eye's drainage system. A condition called pigment dispersion syndrome (PDS), where pigment granules are shed from the iris into the eye's anterior chamber, can lead to pigmentary glaucoma. The iris tissue's backward bowing during eye movements causes pigment to be released from the iris pigment epithelium. Mechanical contact between the iris and the lens or iris and corneal structures may contribute to pigment release. Certain anatomical traits, such as a more concave iris shape, increase the risk of pigment dispersion.

Key Symptoms: Gradual loss of peripheral vision Blurring or difficulty seeing clearly Halos around lights Eye redness or discomfort Eye pain in some cases Enlarged or cloudy appearance of the anterior chamber angles upon examination

Diagnosis Path: Diagnosis involves a comprehensive eye examination, including measuring the intraocular pressure with tonometry, visual field testing to assess peripheral vision, and gonioscopy to evaluate the drainage angles. An ophthalmologist may also examine the anterior chamber for pigment deposits and perform imaging studies such as ultrasound biomicroscopy. Recognizing the characteristic signs of pigment dispersion and elevated IOP aids in diagnosing pigmentary glaucoma, especially when it involves only one eye.

Treatment Protocols: Managing pigmentary glaucoma aims to lower intraocular pressure to prevent optic nerve damage. Typical treatments include: - Topical medications such as prostaglandin analogs, beta-blockers, or alpha-agonists to reduce IOP. - Laser procedures like trabeculoplasty to improve aqueous humor drainage. - In some cases, surgical interventions such as trabeculectomy or tube shunt implantation may be necessary. Regular monitoring of eye pressure and optic nerve health is vital for individuals with this condition to prevent vision loss.